AI is spitting out more potential drugs than ever. This startup wants to figure out which ones matter.

In a landscape where AI generates an unprecedented volume of potential drug candidates, 10x Science is stepping up to streamline the selection process. The startup has successfully secured a $4.8 million seed round to empower pharmaceutical researchers in deciphering complex molecules. This funding will support innovative approaches to evaluate the relevance and efficacy of new compounds, transforming how drug discovery unfolds. By focusing on what truly matters, 10x Science aims to enhance the future of pharmaceuticals and improve patient outcomes.